Home Adaptimmune IPO Well Received By Wall Street With Plenty Of Upside Left
 

Keywords :   


Adaptimmune IPO Well Received By Wall Street With Plenty Of Upside Left

2015-05-09 12:27:58| Biotech - Topix.net

Adaptimmune Therapeutics made its initial public offering on May 6 for $17 per share. The company is a clinical trial stage biotech researching immunotherapies that use T-cell platform technology.

Tags: left street received wall

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
14.1115kg 50mm
14.11ONE PIECE BOX
14.11DAIWA OCEAN STAR 500
14.11fender jhon mayer blackone
14.11 Angel Touch Plus vol.3
14.11Strymon BigSky
14.11
14.11 TOUR B X 2
More »